U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H12N4O2S2
Molecular Weight 284.358
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SULFAETHIDOLE

SMILES

CCC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1

InChI

InChIKey=SVYBEBLNQGDRHF-UHFFFAOYSA-N
InChI=1S/C10H12N4O2S2/c1-2-9-12-13-10(17-9)14-18(15,16)8-5-3-7(11)4-6-8/h3-6H,2,11H2,1H3,(H,13,14)

HIDE SMILES / InChI
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Sul-Spansion

Approved Use

Urinary tract infections

Launch Date

-3.73420786E11
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
125 μg/mL
1 g single, oral
dose: 1 g
route of administration: Oral
experiment type: SINGLE
co-administered: DICLOXACILLIN
SULFAETHIDOLE serum
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
2.5%
SULFAETHIDOLE plasma
Homo sapiens
population: UNKNOWN
age: UNKNOWN
sex: UNKNOWN
food status: UNKNOWN
Sourcing
PubMed

PubMed

TitleDatePubMed
Drug absorption VII: influence of mesenteric blood flow on intestinal drug absorption in dogs.
1975 Apr
Influence of sulfaethidole on the human pharmacokinetics of dicloxacillin.
1980 Aug-Sep
Pharmacokinetics of sulfaethidole in the rat: nonlinear multicompartment solution.
1982 Feb
Patents

Sample Use Guides

Urinary tract infections Adult: 1.5-4 g/day in 3-4 divided doses. Child: 30-45 mg/kg/day in 4 divided doses.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
SULFAETHIDOLE
INN   MI   WHO-DD  
INN  
Official Name English
Sulfaethidole [WHO-DD]
Common Name English
sulfaethidole [INN]
Common Name English
SUL-SPANSION
Brand Name English
SULPHAETHIDOLE
Common Name English
SULFAETHIDOLE [MI]
Common Name English
BENZENESULFONAMIDE, 4-AMINO-N-(5-ETHYL-1,3,4-THIADIAZOL-2-YL)-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C29739
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
Code System Code Type Description
EVMPD
SUB10701MIG
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY
MERCK INDEX
m10309
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY Merck Index
DRUG CENTRAL
2504
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY
FDA UNII
R77Q4O5ZMD
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY
ChEMBL
CHEMBL1355299
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY
PUBCHEM
7181
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY
MESH
C100299
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY
NCI_THESAURUS
C152455
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY
RXCUI
37324
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY RxNorm
SMS_ID
100000083247
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY
INN
749
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY
CAS
94-19-9
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY
EPA CompTox
DTXSID4046286
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY
ECHA (EC/EINECS)
202-312-4
Created by admin on Fri Dec 15 15:18:19 UTC 2023 , Edited by admin on Fri Dec 15 15:18:19 UTC 2023
PRIMARY